Idaho Senate approves Bill 12 11 for over-the-counter ivermectin access

Idaho residents may soon have greater access to ivermectin, a medication long approved by the FDA for treating parasitic infections, as the House State Affairs Committee discussed Senate Bill 1211 during their meeting on April 3, 2025. This bill aims to allow over-the-counter sales of ivermectin, which has garnered attention for its safety and efficacy, particularly in rural areas where healthcare access is limited.

Representative Redmond, who presented the bill, emphasized that many Idahoans are currently seeking ivermectin through off-label prescriptions or unregulated online sources. By making it available over the counter, the bill seeks to provide a safer alternative, allowing local pharmacies to dispense human-grade ivermectin with professional guidance. This move is intended to empower patients, particularly in underserved regions, to make informed decisions about their healthcare.

The bill has already passed the Senate with a strong majority and is seen as a way to enhance patient autonomy, similar to how naloxone is available over the counter to combat opioid overdoses. Redmond highlighted that pharmacists would play a crucial role in educating patients about proper use and dosing, reinforcing their position as frontline healthcare providers.

During the meeting, committee members raised questions about the active ingredient concentration in over-the-counter ivermectin and the experiences of other states, such as Arkansas and Tennessee, which have already approved similar legislation. The discussion underscored the growing interest in expanding access to this medication, with 13 other states also considering similar measures.

As the committee moved to recommend the bill for further consideration, the implications of Senate Bill 1211 could significantly impact healthcare accessibility for many Idahoans, particularly those in rural communities. If passed, this legislation would mark a notable shift in how ivermectin is accessed and utilized in the state, potentially improving health outcomes for residents facing challenges in obtaining necessary treatments.